NCT06322537

Brief Summary

All heart surgery patients universally require hydration, which is given through a vein in the arm, but practices for treating patients are not universal. There are disagreements about whether crystalloids should be used alone or in combination with albumin. This question has important implications because albumin is an expensive blood product in relatively limited supply, and 20% of its use is by heart surgery patients. The goal of this study is to learn more about how crystalloids and albumin are used during heart surgery, as well as, key patient outcomes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
505

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

10 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 21, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 23, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

1.5 years

First QC Date

February 21, 2024

Last Update Submit

November 20, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Albumin

    Type, dose and timing of administration, the setting in which it was ordered, indication for use, and the type of provider responsible for the patient at administration (surgeon, anesthesiologist, intensivist, nurse practitioner).

    On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28.

  • Crystalloid, volume dose and type administered

    Type and volume of crystalloid given (Normal saline, Ringer's Lactate, Plasmalyte-148, and others), as well as the setting of administration will be recorded.

    On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28.

Study Arms (1)

Cardiac Surgery Patients

Adult (≥18 years old) patients who have undergone cardiac surgery.

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will include up to 500 adult (≥18 years old) patients who have undergone major cardiac surgery. All adult (≥18 years old) patients who have undergone cardiac surgery (with or without the use of cardio-pulmonary bypass) will be eligible. There are no specific exclusion criteria.

You may qualify if:

  • Adult (≥18 years old)
  • Cardiac surgery with the use of cardiopulmonary bypass
  • Cardiac surgery without the use of cardiopulmonary bypass

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Royal Columbian Hospital

New Westminster, British Columbia, V3L 3W7, Canada

Location

Vancouver General Hospital

Vancouver, British Columbia, V5Z 1M9, Canada

Location

Nova Scotia Health Authority

Halifax, Nova Scotia, B3H 3A6, Canada

Location

McMaster University Medical Centre

Hamilton, Ontario, Canada

Location

Kingston Health Sciences Centre

Kingston, Ontario, K7L 3N6, Canada

Location

London Health Science Centre

London, Ontario, N6A 5A5, Canada

Location

University of Ottawa Heart Institute

Ottawa, Ontario, K1Y 4W7, Canada

Location

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

Location

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

Toronto General Hospital - University Health Network

Toronto, Ontario, M5G 2C4, Canada

Location

Study Officials

  • Keyvan Karkouti, MD MSc FRCPC

    Toronto General Hospital - University Health Network

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2024

First Posted

March 21, 2024

Study Start

May 23, 2024

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

November 26, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations